News

Foamix news releases

Stay up-to-date on the latest news and innovation from Foamix

 

November 11, 2019
Foamix Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Conference Call and Webcast Scheduled for Monday, November 11th at 8:30am Eastern Time REHOVOT, Israel , and BRIDGEWATER, N.J. , Nov. 11, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and
October 23, 2019
Foamix Enters Into Manufacturing and Supply Agreement For AMZEEQ™ and FMX103
Triggers availability of non-dilutive capital under existing credit agreement with Perceptive and OrbiMed REHOVOT, Israel and BRIDGEWATER, N.J. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today
October 21, 2019
Foamix Announces Settlement of Litigation with Teva Relating to Finacea Foam
REHOVOT, Israel and BRIDGEWATER, N.J. , Oct. 21, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced that, together with LEO Pharma A/S (“LEO Pharma”) it has entered into a settlement and license